Clinical Trial Detail

NCT ID NCT03020030
Title Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements yes
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphocytic leukemia

Therapies

Nelarabine

dexrazoxane

Asparaginase

Vincristine

Cyclophosphamide

Cytarabine

Mercaptopurine

Pegaspargase

Methotrexate

Etoposide

Doxorubicin

Dexamethasone

Prednisone

Dasatinib

Leucovorin

Age Groups: child adult

Additional content available in CKB BOOST